These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 38770543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early renal impairment affects hormonal regulators of calcium and bone metabolism and Wnt signalling and the response to vitamin D supplementation in healthy older adults.
    Christodoulou M, Aspray TJ, Piec I, Washbourne C, Tang JCY, Fraser WD, Schoenmakers I, VDOP Trial group, Terry J Aspray, Roger M Francis, Elaine McColl, Thomas Chadwick, Ann Prentice, Inez Schoenmakers.
    J Steroid Biochem Mol Biol; 2023 May; 229():106267. PubMed ID: 36739953
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
    van Breda F, Emans ME, van der Putten K, Braam B, van Ittersum FJ, Kraaijenhagen RJ, de Borst MH, Vervloet M, Gaillard CA.
    PLoS One; 2015 May; 10(6):e0128994. PubMed ID: 26079688
    [Abstract] [Full Text] [Related]

  • 5. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
    Liu Z, Zhou H, Chen X, Chen H, Wang Y, Wang T, Cai L, Hong Y, Ke H, Zheng J.
    Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
    [Abstract] [Full Text] [Related]

  • 6. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.
    Dounousi E, Torino C, Pizzini P, Cutrupi S, Panuccio V, D'Arrigo G, Abd ElHafeez S, Tripepi G, Mallamaci F, Zoccali C.
    Eur J Clin Invest; 2016 Mar; 46(3):234-41. PubMed ID: 26728476
    [Abstract] [Full Text] [Related]

  • 7. Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
    Emrich IE, Brandenburg V, Sellier AB, Schauerte J, Wiedenroth J, Untersteller K, Lennartz CS, Seiler-Mussler S, Wagenpfeil S, Fliser D, Heine GH.
    Am J Nephrol; 2019 Mar; 49(3):203-211. PubMed ID: 30808827
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vitamin D Supplementation for 12 Months in Older Adults Alters Regulators of Bone Metabolism but Does Not Change Wnt Signaling Pathway Markers.
    Christodoulou M, Aspray TJ, Piec I, Washbourne C, Tang JC, Fraser WD, Schoenmakers I, VDOP Trial Group.
    JBMR Plus; 2022 May; 6(5):e10619. PubMed ID: 35509637
    [Abstract] [Full Text] [Related]

  • 10. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients.
    Yamashita K, Mizuiri S, Nishizawa Y, Kenichiro S, Doi S, Masaki T.
    Nephrology (Carlton); 2017 Dec; 22(12):947-953. PubMed ID: 27558654
    [Abstract] [Full Text] [Related]

  • 11. Phosphate control in reducing FGF23 levels in hemodialysis patients.
    Rodelo-Haad C, Rodríguez-Ortiz ME, Martin-Malo A, Pendon-Ruiz de Mier MV, Agüera ML, Muñoz-Castañeda JR, Soriano S, Caravaca F, Alvarez-Lara MA, Felsenfeld A, Aljama P, Rodriguez M.
    PLoS One; 2018 Dec; 13(8):e0201537. PubMed ID: 30086150
    [Abstract] [Full Text] [Related]

  • 12. Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease.
    Lerch C, Shroff R, Wan M, Rees L, Aitkenhead H, Kaplan Bulut I, Thurn D, Karabay Bayazit A, Niemirska A, Canpolat N, Duzova A, Azukaitis K, Yilmaz E, Yalcinkaya F, Harambat J, Kiyak A, Alpay H, Habbig S, Zaloszyc A, Soylemezoglu O, Candan C, Rosales A, Melk A, Querfeld U, Leifheit-Nestler M, Sander A, Schaefer F, Haffner D, 4C study consortium, ESPN CKD-MBD working group.
    Nephrol Dial Transplant; 2018 Dec 01; 33(12):2208-2217. PubMed ID: 29481636
    [Abstract] [Full Text] [Related]

  • 13. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.
    Hu MC, Reneau JA, Shi M, Takahashi M, Chen G, Mohammadi M, Moe OW.
    Am J Physiol Renal Physiol; 2024 Apr 01; 326(4):F584-F599. PubMed ID: 38299214
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.
    Kendrick J, Andrews E, You Z, Moreau K, Nowak KL, Farmer-Bailey H, Seals DR, Chonchol M.
    Clin J Am Soc Nephrol; 2017 Sep 07; 12(9):1438-1446. PubMed ID: 28784657
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.